ArticleBMC palliative care2016
'I don't think I'd be frightened if the statins went': a phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.
Article in BMC palliative care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 5 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review.BMJ open · 2022Pooled it
- Attitudes Towards Deprescribing Among Older Adults with Limited Life Expectancy and Their Relatives: A Systematic Review.Drugs & aging · 2020Pooled it
- Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines.Journal of the American Geriatrics Society · 2020Pooled it
- Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.British journal of clinical pharmacology · 2019Pooled it
- Patient beliefs and attitudes to taking statins: systematic review of qualitative studies.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018Pooled it
- Physical Activity and Nutritional Supportive Care Needs Following a Sarcoma Diagnosis: Barriers and Opportunities for Rare Cancer Survivorship Care.Psycho-oncology · 2026Article
- Deprescribing for patients nearing end of life: views, barriers and facilitators of palliative care patients, carers and nurses.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- 'Do I actually even need all these tablets?' A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members.Palliative medicine · 2025Article
- Understanding Experiences of Telehealth in Palliative Care: Photo Interview Study.JMIR human factors · 2025Article
- Factors influencing deprescribing in primary care for those towards the end of life: A qualitative interview study with patients and healthcare practitioners.Palliative medicine · 2024Article
- Appropriate medication use in Dutch terminal care: study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study).BMC palliative care · 2024Article
- DEprescribing: Perceptions of PAtients living with advanced cancer. A multicentre, prospective mixed observational study protocol.PloS one · 2024Article
- Medication work among nonagenarians: a qualitative study of the Newcastle 85+ cohort participants at 97 years old.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023Article
- Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.International journal of clinical pharmacy · 2022Article
- Palliative Care: A Primary Care Pharmacist Perspective.Pharmacy (Basel, Switzerland) · 2022Article
- How timely is access to palliative care medicines in the community? A mixed methods study in a UK city.BMJ open · 2019Article
- How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.Palliative medicine · 2019Article
- Article
- Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life - an international cohort study.British journal of clinical pharmacology · 2018Article
- Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 3 countries.
Funding
Abstract
backgroundThere is a growing body of evidence suggesting patients with life-limiting illness use medicines inappropriately and unnecessarily. In this context, the perspective of patients, their carers and the healthcare professionals responsible for prescribing and monitoring their medication is important for developing deprescribing strategies. The aim of this study was to explore the lived experience of patients, carers and healthcare professionals in the context of medication use in life-limiting illness.
methodsIn-depth interviews, using a phenomenological approach: methods of transcendental phenomenology were used for the patient and carer interviews, while hermeneutic phenomenology was used for the healthcare professional interviews.
resultsThe study highlighted that medication formed a significant part of a patient's day-to-day routine; this was also apparent for their carers who took on an active role-as a gatekeeper of care-in managing medication. Patients described the experience of a point in which, in their disease journey, they placed less importance on taking certain medications; healthcare professionals also recognize this and refer it as a 'transition'. This point appeared to occur when the patient became accepting of their illness and associated life expectancy. There was also willingness by patients, carers and healthcare professionals to review and alter the medication used by patients in the context of life-limiting illness.
conclusionsThere is a need to develop deprescribing strategies for patients with life-limiting illness. Such strategies should seek to establish patient expectations, consider the timing of the discussion about ceasing treatment and encourage the involvement of other stakeholders in the decision-making progress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.